Home › Drug Product Listings › Brigatinib

Brigatinib

Trade Name: 
Alunbrig
Manufacturer/Distributor: 
Takeda Canada Inc.
www.takeda.com/en-ca
Classification: 
Antineoplastic agent
ATC Class: 
B01XE43 - brigatinib
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2018/07/26
Date Marketed in Canada (yyyy/mm/dd): 
2018/07/26
Presentation: 
Tablet: 30 mg. DIN: 02479206
Tablet: 90 mg. DIN: 02479214
Tablet: 180 mg. DIN: 02479222
Comments: 
Notice of compliance with conditions for treatment of adults with anaplastic lymphoma kinase positive metastatic non-small cell lung cancer.
Source: 
Product monograph
Back to: 
Drug Product Listings
  • Share this
  • Printer-friendly version
  • PDF version